PER 3.57% 8.7¢ percheron therapeutics limited

Ann: Positive feedback received on Paediatric Investigation Plan, page-48

  1. 13,207 Posts.
    lightbulb Created with Sketch. 1398
    Let’s not lose heart because of the stagnant sp…

    https://www.ihealthcareanalyst.com/global-idiopathic-pulmonary-fibrosis-treatment-market/

    The market for fibrosis is $8 billion by 2027…
    Thats larger than the DMD market..

    So just on DMD and fibrosis Anp has a market of $13 billion… with no competition…

    In 16 months Anp could be earning $1 billion per annum..

    At the moment we have aMC of $127 million

    its a joke….

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.